Patents by Inventor Eric Blough

Eric Blough has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10398732
    Abstract: Compositions and methods for treating striated muscle injury, treating striated muscle atrophy, and/or for promoting striated muscle growth are provided and include administering zinc oxide nanoparticles to a subject in need thereof. The zinc oxide nanoparticles can be adminstered before, during, and/or after exposure to an injurious stimuli, such as radiation. Administration of the zinc oxide nanoparticles reduces activation of autophagy regulators, increases striated muscle anabolism, increases DNA repair signaling, and/or increases striated muscle protein synthesis and growth.
    Type: Grant
    Filed: October 13, 2017
    Date of Patent: September 3, 2019
    Assignee: MARSHALL UNIVERSITY RESEARCH CORPORATION
    Inventors: Miaozong Wu, Cuifen Wang, Eric Blough
  • Publication number: 20180104276
    Abstract: Compositions and methods for treating striated muscle injury, treating striated muscle atrophy, and/or for promoting straited muscle growth are provided and include administering zinc oxide nanoparticles to a subject in need thereof. The zinc oxide nanoparticles can be adminstered before, during, and/or after exposure to an injurious stimuli, such as radiation. Adminstration of the zinc oxide nanoparticles reduces activation of autophagy regulators, increases striated muscle anabolism, increases DNA repair signaling, and/or increases striated muscle protein synthesis and growth.
    Type: Application
    Filed: October 13, 2017
    Publication date: April 19, 2018
    Inventors: Miaozong WU, Cuifen WANG, Eric BLOUGH
  • Patent number: 9669055
    Abstract: Methods for treating sepsis are provided and include the administration an effective amount of cerium oxide nanoparticles to a subject in need thereof. The sepsis being treated can include polymicrobial sepsis and can include the administration of about 0.1 mg/kg to about 1.0 mg/kg of the cerium oxide nanoparticles. The administration of the cerium oxide nanoparticles further allows one or more of the symptoms of sepsis to be treated. Methods of treating an inflammatory disorder that make use of cerium oxide nanoparticles are further provided.
    Type: Grant
    Filed: April 13, 2015
    Date of Patent: June 6, 2017
    Assignee: Marshall University Research Corporation
    Inventors: Eric Blough, Nandini Manne, Selvaraj Vellaisamy